| Literature DB >> 32255248 |
Media K Ismail1, Zahra Khan2, Marium Rana1, Sarah L Horswell1, Louise Male1, Huy V Nguyen1, Alessio Perotti2, Isolda Romero-Canelón3, Edward A Wilkinson1, Nikolas J Hodges2, James H R Tucker1.
Abstract
Four new bis-substituted ferrocene derivatives containing either a hydroxyalkyl or methoxyalkyl group and either a thyminyl or methylthyminyl group have been synthesised and characterised by a range of spectroscopic and analytical techniques. They were included in a structure-activity-relationship (SAR) study probing anticancer activities in osteosarcoma (bone cancer) cell lines and were compared with a known lead compound, 1-(S,Rp ), a nucleoside analogue that is highly toxic to cancer cells. Biological studies using the MTT assay revealed that a regioisomer of ferronucleoside 1-(S,Rp ), which only differs from the lead compound in being substituted on two cyclopentadienyl rings rather than one, was over 20 times less cytotoxic. On the other hand, methylated derivatives of 1-(S,Rp ) showed comparable cytotoxicities to the lead compound. Overall these studies indicate that a mechanism of action for 1-(S,Rp ) cannot proceed through alcohol phosphorylation and that its geometry and size, rather than any particular functional group, are crucial factors in explaining its high anticancer activity.Entities:
Keywords: Ferrocene; anticancer; bioorganometallic; metallodrug; nucleoside analogue
Mesh:
Substances:
Year: 2020 PMID: 32255248 DOI: 10.1002/cbic.202000124
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.461